Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
XTractor™ a Pioneering Literature Alert Service with Unlimited Free Access Creates a User Base of Over 250 Premier Organizations Worldwide in Less Than 9 Months
Molecular Connections announced today, XTractor™, the first of its kind manually curated literature alert service has built a user base of over 250 premier organizations in less than 9 months from its launch. Also shortly launching the Premium commercial version of XTractor™, with significantly enhanced features – like Biblographic & Semantic searches etc. The knowledgebase currently includes more than 100000 relationships, and grows at the rate of more than 600 relationships everyday. - February 16, 2009 - Molecular Connections Pvt. Ltd.
Newly Formed: D2 Pharma Consulting LLC Focused on Commercialization Excellence
D2 Pharma Consulting LLC (D2) is a newly formed, best-in-class consulting firm, exclusively focusing on pharma services in the life sciences industry. D2 assists emerging and established pharmaceutical and biopharmaceutical companies to develop and execute strategic business initiatives, ensuring successful launch, distribution and ongoing leadership position in the marketplace. - February 16, 2009 - D2 Pharma Consulting LLC
Anavex Appoints Leading Alzheimer's Disease Expert Dr. Mark Smith to Scientific Advisory Board
Anavex Life Sciences Corp. today announced the appointment of Dr. Mark A. Smith, Ph.D., FRCPath, to its scientific advisory board. - February 12, 2009 - Anavex Life Sciences Corp.
Clinical Trials in Russia. Year 2008.
On February 04, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Year 2008, a regular analytical report on the clinical trial market in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering... - February 07, 2009 - Synergy Research Group
Pharmaceutical ERP Software on Display at INTERPHEX
Deacom, Inc. will exhibit its integrated accounting and ERP Software System for pharmaceutical manufacturers at INTERPHEX, the premier event for the pharmaceutical and biopharmaceutical industries, on March 17-19 at the Jacob K. Javits Convention Center in New York, NY. - February 06, 2009 - Deacom
Medimix International CEO, Henry Gazay, to Present Session "Brave New Worlds: Emergence of Innovation in the E7 Countries" at PBIRG's AGM - May 17-20, 2009
Henry Gazay, CEO of Medimix International, will present at a University Session May 18th at the Pharmaceutical Business Intelligence and Research Group’s AGM in Phoenix, Arizona. The presentation will focus on the specific challenges and opportunities presented by marketing to the extremely diverse cultures of the E7 “pharmerging markets,” with particular emphasis on what are known as the BRIC countries (Brazil, China, India, and China). - February 04, 2009 - Medimix International
Anavex Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer’s Disease Study
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) has signed an agreement with organic chemistry services provider Syntagon AB (“Syntagon”) for the scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. ANAVEX 2-73 is... - February 04, 2009 - Anavex Life Sciences Corp.
Pharmaceutical Processing Magazine Cover Features Cerulean’s 2009 FDA Forecast Under the Obama Administration
Under the Democratic Congress and the Obama administration, the US Food and Drug Administration will take an increasingly tougher line with pharmaceutical, biotech and medical device executives; this according to a new analysis published last week in Pharmaceutical Processing magazine. - January 29, 2009 - Cerulean Associates LLC
LegalView Updates Avandia Information Portal with New Articles Detailing Potentially Dangerous Side Effects
LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among patients. - January 28, 2009 - LegalView
Boston-Based Company Illuminate Keeps Pharmaceutical Sales Training on Top of Agenda
Illuminate starts 2009 with support and new project development that keep pharmaceutical sales training a priority. - January 28, 2009 - Illuminate, Inc.
IonSense Announces the Expansion of DART® Ion Source Product Line to Include TOF Mass Spectrometers
The Popular Direct Analysis Technique is Now Available for Time-of-Flight Instruments, Expanding the Range of Applications. - January 27, 2009 - IonSense, Inc.
IMA World Health Receives $250,000 Gift from F. Dohmen Foundation
IMA World Health, a Maryland-based global health care nonprofit, was one of the first to receive a gift from a newly-formed foundation of the F. Dohmen Company. - January 24, 2009 - IMA World Health
Susan Richards, PhD, Group VP of Clinical Laboratory Sciences at Genzyme to Give Keynote Presentation at GTCbio’s 3rd Immunodiagnostics & Immunomonitoring Conference
Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference. - January 24, 2009 - GTCbio
Medimix International Opens Regional Asian Office in Hong Kong, China - Online Healthcare Panel Developing in Asian Countries
One of the “pharmerging markets,” China represents a fascinating new frontier and an enormous challenge to companies as we move into 2009. Medimix International celebrates 20th year with expansion of its network and services, opening Medimix Asia. - January 24, 2009 - Medimix International
Integrated ERP Lot Tracking Eases Compliance, Recall Issues for Pharmaceutical Manufacturing
The DEACOM Integrated Accounting and Enterprise Resource Planning (ERP) Software System, produced by Deacom, Inc., integrates lot tracking functionality with all the business processes of a pharmaceutical manufacturer in a single software system. - January 22, 2009 - Deacom
Thomas Waldmann, Chief of the Metabolism Branch at the NCI to Give Keynote Speech at 3rd Immunodiagnostics & Immunomonitoring Conference
Thomas A. Waldmann, M.D., Chief of the Metabolism Branch at the NCI, NIH will give the keynote presentation at GTCbio’s at 3rd Annual Immunodiagnostics & Immunomonitoring Conference on April 23-24, 2009 in Chicago, IL. - January 08, 2009 - GTCbio
BioSoteria’s Growth Continues with 29 New Clients in 2008
BioSoteria, the leading West Coast provider of drug safety and risk management consulting and educational services, showed significant growth in 2008 with 29 new clients for the year, more than doubling the clients from 2007. - January 08, 2009 - BioSoteria
MedPro Rx, Inc. Sponsors “Hearts for Hemophilia” Casino Night
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy is a Jack of Hearts sponsor for Hemophilia of North Carolina’s “Hearts for Hemophilia” casino night. The... - January 01, 2009 - MedPro Rx, Inc.
Illuminate Rings in the Year's End
The holiday season brought Illuminate’s employees, extended employees, family and friends to a gathering celebrating the end of the year at the president’s home in Boston. - December 28, 2008 - Illuminate, Inc.
LegalView Reports FDA Delay of Drug That Might Prevent OxyContin Drug Abuse
LegalView informed readers of a new drug that would likely replace OxyContin and prevent the abuse commonly associated with consuming a prescription pain medication. The FDA has delayed the release of the drug requesting more information on it, but no additional clinical trials. - December 26, 2008 - LegalView
LegalView Updates Its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
LegalView informed individuals of recent conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. The FDA has claimed that Baxter's Heparin was not the cause of death among several patients, but the agency has also alleged that that the tainted blood thinner likely did cause death among patients. - December 26, 2008 - LegalView
Casey Petraceuticals Announces Distribution to 450 Drug Stores
Casey Petraceuticals LLC announced a distribution agreement with Mutual Drug Company, a cooperative owned and managed by over 450 member pharmacists throughout North Carolina, South Carolina, and Virginia. Casey Petraceuticals President Jon Turner announced that the company had received the initial... - December 22, 2008 - Casey Petraceuticals LLC
Ground-Breaking Anti-Amnesic and Neuroprotective Effects of Alzheimer's Compound ANAVEX 1-41 Published in Journal of Neuropsychopharmacology
Anavex Life Sciences Corp. (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announces that the anti-amnesic and neuroprotective effects of ANAVEX 1-41 are detailed in a paper... - December 19, 2008 - Anavex Life Sciences Corp.
Anavex Presents Potent Neuroprotective Effects of Anavex 1-41 at Neuroscience 2008
Anavex Life Sciences Corp., a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, was selected to present its latest results with ANAVEX 1-41 at Neuroscience 2008, the 38th annual meeting of the Society... - December 17, 2008 - Anavex Life Sciences Corp.
Illuminate Celebrates the Holiday Season
Illuminate, the Boston based pharmaceutical training Solutions Company, continues its tradition of celebration and joy this holiday’s season through their Happy Thanksgiving and Happy Holidays cards. - December 16, 2008 - Illuminate, Inc.
Integrated Clinical Trial Services Releases Podcast on Patient Retention Tools
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced the release of a podcast... - December 14, 2008 - Integrated Clinical Trial Services
Healthcare Scouts Attended the 43rd ASHP American Society of Health-System Pharmacists Meeting and Exhibition conducted December 7-11, 2008 in Orlando Florida
The 43rd ASHP American Society of Health-System Pharmacists Meeting and Exhibition theme this year was the “power of you”. Over 18,000 attendees gathered in the Orange County Convention Center with many highlights, including Elizabeth Edward’s “An Inspiring Life”... - December 13, 2008 - Healthcare Scouts
Nancy McFarlane Named 2008 Women Extraordinaire
MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that Nancy McFarlane, president of the pharmacy, has been named a Women Extraordinaire 2008 recipient by Business Leader magazine. The Women Extraordinaire awards recognize... - December 11, 2008 - MedPro Rx, Inc.
Allegro 3D Biocontainers Available from Pall Life Sciences -- High Clarity, Gas Impermeable to Protect Products During Single-Use Biotech, Pharmaceutical Processes
Pall Allegro™ 3D biocontainers from Pall Life Sciences are available worldwide. Specifically designed to enhance the performance of the company’s single-use systems for large-scale biotechnology and pharmaceutical manufacturing applications. - December 10, 2008 - Pall Corporation
MedPro Rx, Inc. Releases Podcast on Scholarship Program for Students with Bleeding Disorders
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced the release of a podcast about the pharmacy’s “Education Is Power” scholarship program. In the podcast, Kathy... - December 06, 2008 - MedPro Rx, Inc.
Dr. David Shearer of Integrated Clinical Trial Services Nominated for Drug Information Association Board of Directors
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that David M. Shearer, MD,... - December 04, 2008 - Integrated Clinical Trial Services
LegalView Updates Avandia Information Portal with News That Avandia May be More Dangerous Than Similar Drugs
LegalView recently relaunched is Avandia information portal with updated news that the type 2 diabetes drug has more safety risks than drugs of a similar nature. A study from U.S. researchers was published evaluating the dangers of the diabetes drugs and found Avandia as riskier for patients than Actos. - December 02, 2008 - LegalView
MedPro Rx, Inc. Names Senior Vice President of Sales and Marketing
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that Brad Andrews has been named senior vice president of sales and marketing. In this position, Andrews works as part of the senior... - November 28, 2008 - MedPro Rx, Inc.
Will European Transport Hub Stay Cool Under Pressure?
Brussels International Airport will receive a visit from cold chain supply experts as part of IQPC’s 8th Cool Chain Europe Conference. - November 23, 2008 - IQPC
MedPro Rx, Inc. Accepting Scholarship Applications
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced applications are now open for their “Education Is Power” scholarship program. The annual scholarships are open to United States... - November 22, 2008 - MedPro Rx, Inc.
RNCOS Releases a New Report- Ukraine Pharma - New Opportunities for Growth
RNCOS has recently added a new Market Research Report titled, “Ukraine Pharma - New Opportunities for Growth” to its report gallery. According to the new research report, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian... - November 22, 2008 - RNCOS
FDA to Share Perspective on Polymorphic Forms in Abbreviated New Drug Applications (ANDAs)
The FDA will make a presentation on ANDA's at the IQPC Polymorphism & Crystallisation Conference 2009. - November 22, 2008 - IQPC
Arrowhead Publishers Releases New Report Analyzing the Global Cancer Therapy Market
A New report from Arrowhead Publishers entitled Cancer Therapeutics: Market Insight and R&D Pipeline Analysis (http://www.arrowheadpublishers.com/reports/oncology/cancer-therapeutics-2008/) provides valuable insight into the global market for cancer therapies and developmental-stage therapies. - November 21, 2008 - Arrowhead Publishers and Conferences
Integrated Clinical Trial Services Releases Podcast on Effective Site Selection
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced the release of a podcast... - November 20, 2008 - Integrated Clinical Trial Services
Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot
Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion channel screening. - November 20, 2008 - Nanion Technologies GmbH
GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference
GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida. The conference will take attendees through “The Life Cycle of a Cancer Biomarker”; examining the path from the identification of a candidate biomarker, development... - November 19, 2008 - GTCbio
Saint-Gobain, AdvantaPure(R) Settle Patent Infringement Allegations Over Molded Tubing Sets; Licensing Agreement Entered Into
Saint-Gobain Performance Plastics Corporation and NewAge(R) Industries/AdvantaPure have resolved a dispute regarding patents on tubing and connector technology. The two companies have entered into a licensing agreement. U.S. patent numbers 7,093,859 and 6,290,265 were at issue. - November 19, 2008 - NewAge Industries, Inc.
XTractor™ - a Powerful Scientific Literature Alert Service with Unlimited Free Access Creates a User Base of Over 900 Users from 150 Premier Organizations Worldwide
Molecular Connections announced today, that XTractor™ the first of its kind manually curated literature alert service has built a user base of over 900 from more than 150 premier organizations in less then 4 months from its launch. XTractor™ has been widely accepted and well received among the scientific fraternity both in the academia and the industry across the globe. - November 15, 2008 - Molecular Connections Pvt. Ltd.
Premarin Vaginal Cream FDA-Approved for Dyspareunia (Painful Intercourse)
The FDA has approved Premarin Vaginal Cream as the first prescription vaginal cream for postmenopausal dyspareunia (painful sexual intercourse). - November 13, 2008 - Wyeth Pharmaceuticals
Healthcare Communications Group Expands Global Operations
Leading Pharmaceutical Clinical Trial Recruitment Firm Opens Offices in London and Singapore, Establishes New International Delivery Capabilities, Engages Medical Advisor, and Introduces New Global Technologies. - November 12, 2008 - Healthcare Communications Group
Integrated Clinical Trial Services Wins Triangle Business Journal’s Fast 50 Award
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS) (www.integratedtrials.com), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced... - November 12, 2008 - Integrated Clinical Trial Services
MedPro Rx, Inc. Wins Triangle Business Journal’s Fast 50 Award
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the company has won the Triangle Business Journal’s 2008 Fast 50 Award. Evaluated by PricewaterhouseCoopers, LLP, the award... - November 09, 2008 - MedPro Rx, Inc.
Recombinant Human Soluble RANKL (sRANKL) Launched in USA
OYC International Inc. is pleased to announce the launch of recombinant human soluble RANKL (sRANKL) to support osteoporosis and bone metabolism research initiatives. Receptor activator of NF-kB ligand (RANKL), also designated TRANCE, OPGL and ODF, is a member of the TNF family that is expressed... - November 07, 2008 - OYC International, Inc.
Gtcbio Announced Its Inaugural CNS Partnering & Deal-Making Summit
GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA. This event is one of the leading CNS disease partnering forums bringing together members of government, industry and academia to discuss the latest advancements in the field. - November 07, 2008 - GTCbio
Nancy Mcfarlane Featured on Cover of Boom! Magazine
MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that Nancy McFarlane, president of the pharmacy, will be featured on the cover of the November issue of Boom! Magazine, available on newsstands today. The “Fifty... - November 06, 2008 - MedPro Rx, Inc.